Expression of PD-L1 can either be a reactive process of T cell response 3,4, in which case it represents the pre-existing anti-tumor immunity, or be regulated by cancer cell-intrinsic mechanisms and represents tumor-intrinsic immune resistance. Here, CD274 is linked to neoplasm.